The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
Official Title: A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
Study ID: NCT00423306
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of advanced hepatocellular carcinoma
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Miami, Florida, United States
, Atlanta, Georgia, United States
, Boston, Massachusetts, United States
, Kansas City, Missouri, United States
, New York, New York, United States
, Seattle, Washington, United States